AlphAI
alphai — Financial news for AI agents
News
API
MCP
Pricing
Search ticker…
⌘K
Loading...
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension — alphai
